TY - JOUR
AU - Andes, David
AB - Traditionally, many invasive fungal infections were associated with a poor prognosis, because effective therapeutic options were limited. The recent development of new antifungal agents has significantly contributed to the successful treatment of fungal diseases. These drugs offer novel mechanisms of action and expanded spectrums of activity over traditional treatment options. However, with these new agents comes the need for increased awareness of the potential interactions and toxicities associated with these drugs. Therefore, an understanding of the pharmacokinetic and pharmacodynamic properties of the classes of antifungal compounds is vital for the effective management of invasive fungal infections. This review provides a summary of the pharmacologic principles involved in treatment of fungal diseases.
TI - Pharmacology of Systemic Antifungal Agents
JO - Clinical Infectious Diseases
DO - 10.1086/504492
DA - 2006-08-01
UR - https://www.deepdyve.com/lp/oxford-university-press/pharmacology-of-systemic-antifungal-agents-jwFPPoULtI
SP - S28
EP - S39
VL - 43
IS - Supplement_1
DP - DeepDyve
ER -